These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cure of human melanoma lung metastases in nude mice with chronic indomethacin therapy combined with multiple rounds of IL-2: characteristics of killer cells generated in situ. Lala PK; Elkashab M; Kerbel RS; Parhar RS Int Immunol; 1990; 2(12):1149-58. PubMed ID: 2090199 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. Parhar RS; Lala PK J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508 [TBL] [Abstract][Full Text] [Related]
6. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ. Lala PK; Parhar RS Cancer Res; 1988 Mar; 48(5):1072-9. PubMed ID: 3124954 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2. Khoo NK; Chan FP; Saarloos MN; Lala PK Clin Exp Metastasis; 1992 Jul; 10(4):239-52. PubMed ID: 1617832 [TBL] [Abstract][Full Text] [Related]
8. Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2. Parhar RS; Lala PK J Exp Med; 1987 Jan; 165(1):14-28. PubMed ID: 3491867 [TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells. Linnemeyer PA; Pollack SB J Immunol; 1993 May; 150(9):3747-54. PubMed ID: 8386202 [TBL] [Abstract][Full Text] [Related]
10. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. Lala PK; Parhar RS; Singh P Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of murine lymphokine-activated killer (LAK) cell activity by adherent cells. Longley RE; Stewart D; Roe KG; Good RA Cell Immunol; 1989 Jul; 121(2):225-36. PubMed ID: 2786756 [TBL] [Abstract][Full Text] [Related]
12. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells. Saarloos MN; Khoo NK; Lala PK Cancer Res; 1992 Dec; 52(23):6452-62. PubMed ID: 1423293 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood. Dussault I; Miller SC Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817 [TBL] [Abstract][Full Text] [Related]
14. Normal murine and porcine embryos recruit NK cells to the uterus. Croy BA; Waterfield A; Wood W; King GJ Cell Immunol; 1988 Sep; 115(2):471-80. PubMed ID: 3409331 [TBL] [Abstract][Full Text] [Related]
15. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179 [TBL] [Abstract][Full Text] [Related]
16. In vivo generation of decidual natural killer cells from resident hematopoietic progenitors. Chiossone L; Vacca P; Orecchia P; Croxatto D; Damonte P; Astigiano S; Barbieri O; Bottino C; Moretta L; Mingari MC Haematologica; 2014 Mar; 99(3):448-57. PubMed ID: 24179150 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the murine metrial gland for immunological function. Croy BA; Kassouf SA J Reprod Immunol; 1989 Mar; 15(1):51-69. PubMed ID: 2715982 [TBL] [Abstract][Full Text] [Related]
18. Functional studies of human decidua in spontaneous early pregnancy loss: effect of soluble factors and purified CD56+ lymphocytes on killing of natural killer- and lymphokine-activated killer-sensitive targets. Vassiliadou N; Bulmer JN Biol Reprod; 1998 Apr; 58(4):982-7. PubMed ID: 9546729 [TBL] [Abstract][Full Text] [Related]
19. Active suppression of host-versus-graft reaction in pregnant mice. VIII. The uterine decidua-associated suppressor cell is distinct from decidual NK cells. Slapsys RM; Richards CD; Clark DA Cell Immunol; 1986 Apr; 99(1):140-9. PubMed ID: 2944622 [TBL] [Abstract][Full Text] [Related]
20. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2. Clark DA; Chaput A; Walker C; Rosenthal KL J Immunol; 1985 Mar; 134(3):1659-64. PubMed ID: 3871455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]